New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease
A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to the Commission, working alongside...
New treatment approved by NICE offers hope for people living with primary biliary cholangitis
Thousands of primary biliary cholangitis (PBC) patients could benefit from new medication that may help reduce one of its most debilitating symptoms – persistent and severe itching, known as pruritus. Taken as a daily pill, Seladelpar (also called Livdelzi), also...
New research highlights stark inequalities in access to life-saving liver transplants
New research published today reveals a stark reality for people with chronic liver disease in England: despite facing a high risk of death after emergency hospital admission, the vast majority are not receiving a potentially life-saving liver transplant. Published in...